|
|
|
Octamer, Inc. helps to explain a mechanism of cancer cell formation and its potential reversal by one of Octamer's lead products, AntiPARP 1.
Ohmeda , manufactures and markets products for anesthesia and critical care.
Organon: it is the research and development of innovative medicines to improve human health that ultimately defines the company's existence and continued success.
If you are a manufacturer and we have not provided a link to your site, please suggest a site or contact us through our Contact Page.
|
|
|
|
|